Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 2/20 | 0.60 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | IL1RN | P18510 | 1/20 | 0.52 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.48 |
| ▸ | CA9 | Q16790 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 2/20 | 0.42 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.42 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL59151 | 0.85 | KEAP1 (0.64) | KEAP1CA1CA2IL1RNERAP1 | |
| SCHEMBL23141160 | 0.82 | KEAP1 (0.61) | KEAP1CA1CA2IL1RNERAP1 | |
| SCHEMBL9092231 | 0.81 | KEAP1 (0.60) | KEAP1CA1CA2IL1RNERAP1 | |
| SCHEMBL15448405 | 0.79 | CA1 (0.59) | CA1CA2CA12CA9KMT2A | |
| SCHEMBL5388760 | 0.77 | ALDH1A1 (0.36) | KEAP1CA1CA2IL1RNERAP1 | |
| SCHEMBL9464922 | 0.77 | KEAP1 (0.50) | KEAP1CA1CA2CA9KMT2A | |
| SCHEMBL22638695 | 0.77 | CA12 (0.51) | CA1CA2CA12CA9KMT2A | |
| SCHEMBL10192105 | 0.77 | HPGD (0.53) | KMT2AMEN1ALDH1A1PKMGAA | |
| SCHEMBL28590445 | 0.76 | CA2 (0.54) | KEAP1CA1CA2IL1RNERAP1 | |
| SCHEMBL633875 | 0.76 | CA2 (0.60) | KEAP1CA1CA2IL1RNERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113087687-A | Method for direct carbon-hydrogen alkynylation of thioamide-oriented aromatic hydrocarbon | 宁夏大学 | 2021-07-09 | — | — | CN | claimed |
| JP-2597176-B2 | — | — | 1997-04-02 | — | — | JP | claimed |
| WO-1988005630-A1 | FUNGICIDAL COMPOSITIONS | SHELL AGRAR GMBH & CO. KG (DE) | 1988-08-11 | — | — | WO | claimed |
| WO-2021155004-A1 | STRAD-BINDING AGENTS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-08-05 | — | — | WO | disclosed |
| US-20170015649-A1 | N-Thio-anthranilamid compounds and their use as pesticides | BASF SE (DE) | 2017-01-19 | — | — | US | disclosed |
| US-9365543-B2 | N-Thio-anthranilamid compounds and their use as pesticides | BASF SE | 2016-06-14 | — | — | US | disclosed |
| US-20150353523-A1 | N-Thio-anthranilamid compounds and their use as pesticides | BASF SE (DE) | 2015-12-10 | — | — | US | disclosed |
| EP-1238989-B1 | Olefin polymerization catalyst and process for producing olefin polymer with the catalyst | MITSUI CHEMICALS INC (JP) | 2015-10-07 | — | — | EP | disclosed |
| US-9056853-B2 | N-Thio-anthranilamid compounds and their use as pesticides | BASF SE (DE) | 2015-06-16 | — | — | US | disclosed |
| US-20140378458-A1 | N-Thio-anthranilamid compounds and their use as pesticides | BASF SE (DE) | 2014-12-25 | — | — | US | disclosed |
| US-8772289-B2 | N-Thio-anthranilamid compounds and their use as pesticides | BASF SE (DE) | 2014-07-08 | — | — | US | disclosed |
| CN-100390236-C | Method for preparing tetrazo pigment | TOYO INK MFG CO (JP) | 2008-05-28 | — | — | CN | disclosed |
| EP-1904475-A1 | N-THIO-ANTHRANILAMID COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007006670-A1 | N-THIO-ANTHRANILAMID COMPOUNDS AND THEIR USE AS PESTICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-18 | — | — | WO | disclosed |
| US-6897176-B2 | Olefin polymerization catalyst and process for producing olefin polymer with the catalyst | MITSUI CHEMICALS, INC. (JP) | 2005-05-24 | — | — | US | disclosed |
| US-20020169072-A1 | Olefin polymerization catalyst and process for produing Olefin polymer with the catalyst | MITSUI CHEMICALS, INC. (JP) | 2002-11-14 | — | — | US | disclosed |
| EP-1238989-A2 | Olefin polymerization catalyst and process for producing olefin polymer with the catalyst | Mitsui Chemicals, Inc. (JP) | 2002-09-11 | — | — | EP | disclosed |
| CN-1317517-A | Method for preparing tetrazo pigment | TOYO INK MFG CO (JP) | 2001-10-17 | — | — | CN | disclosed |
| WO-1993024008-A2 | MIXTURES OF ACTIVE ANTI-MICROBIAL SUBSTANCES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1993-12-09 | — | — | WO | disclosed |
| EP-0021176-B1 | CEPHALOSPORIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Dr. Karl Thomae GmbH (DE) | 1984-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140378458-A1 | N-Thio-anthranilamid compounds and their use as pesticides | NAT1, AAAS, ACHE | KEAP1 930/4885CA1 303/4885CA2 1085/4885 |
| US-20170015649-A1 | N-Thio-anthranilamid compounds and their use as pesticides | NAT1, AAAS, ACHE | KEAP1 930/4885CA1 303/4885CA2 1085/4885 |
| US-20150353523-A1 | N-Thio-anthranilamid compounds and their use as pesticides | NAT1, AAAS, ACHE | KEAP1 930/4885CA1 303/4885CA2 1085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.